How to stop watery eyes

Watery eyes is when the eyes water and overflow onto the face.

One of the major causes of watery eyes is chronic dry eyes. TheraLife Eye has a powerful watery eyes treatment protocol to help stop tear overproduction. Check out our entire product line of natural products.  

 Causes of Watery Dry Eyes

There are many causes of watery eyes:

• Allergic Conjunctivitis –allergic reaction to irritants such as pollen that cause the eyes to become red, itchy, and watery.

• Conjunctivitis – Also known as “pink eye,” this Is a highly contagious infection causing the eye to become inflamed.

• Common Cold – A viral infection that results in sneezing, runny nose, headache, and watery eyes.
• Scleritis – A disorder of the eye where the sclera becomes intensely red and inflamed, autoimmune.
• External Eyelid Stye – Seen as an infection of the meibomian oil glands located on the eyelid. 
• Allergic Rhinitis – Also known as hay fever. A common condition where the body reacts to specific allergens with sneezing and watery, itchy eyes.
• Chalazion – When one of the oil glands of the upper eyelid becomes blocked and irritated. The eyes will start to be watery.
• Blepharitis – If the eyelash follicles become inflamed, the eyes may water to clear out the pollutants from the area.

All of these conditions can lead to dry eye disease.

Dry Eye and Watery Eyes  

Eye drops don’t work for watery eyes.

It seems contradictory, but a major cause of watery eyes is dry eyes when dry eyes cause the lacrimal glands to produce fewer tears, resulting in inflammation. 

Why watery eyes feels dry?

Prolonged dry eyes not being treated leads to the production of crying tears (reflux tears), controlled by the autonomous system in the brain. The reflux tears are of poor quality, evaporates too quickly, and wash away the lubricants that protect the eyes. Watery eyes lead to dry, irritated eyes that create the vicious cycle of more tear production.  

What is lacrimal stenosis?

Your tear ducts that drain tears away can be blocked – a condition known as lacrimal stenosis. The tear duct can become blocked after nose surgery or trauma.

Older adults who have drooping eyelids due to aging may also develop dry eyes and excessive watery eyes. 

Ectropion – Cause of dry eyes leading to watery eyes

The eyelids sagging is called Ectropion. Eyes may become dry, sore, red, or burning as a result.

Watery Eyes Symptoms

Dry eyes cause excess tear production. The eyes are dry and uncomfortable, raw, blurry vision, foreign body sensation, light sensitivity, and more. Excessive tearing can wash away the vital oils needed to protect the eyes from airborne irritants. Allergies cause itchy and swollen eyes, which can also lead to dry eyes.  

Treatment for Watery Eyes

TheraLife Eye has an all-natural treatment for those who have chronic dry eyes and watery eyes.

There are now oral capsules that relieve burning, painful, dry, watery eyes. TheraLife Eye is clinically proven to alleviate the symptoms associated with chronic dry eyes and stop tear overproduction. The benefits of TheraLife Eye include:

• Restores and revives the body’s own natural ability to produce balanced tears
• Works better than fish oil or flaxseed oil alone
• No need for messy eye drops
• 90-day money-back guarantee

We highly recommend you start with the discounted Chronic Dry Eye Starter Kit.  TheraLife Eye Starter Kit is the best solution for the treatment of watery eyes. It contains TheraLife Eye capsules, cleansers, compresses, and fish oil capsules, finding a total solution that naturally allows your body to produce tears.

Call and talk to a doctor toll-free at 1-877-917-1989 US/Canada.  

References

1. Eye Contact Lens. 2009 Mar;35(2):44-9 –
2. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4349-55 –
3. Surv Ophthalmol. 2001 Mar;45 Suppl 2:S203-10 –
4. . Am J Ophthalmol. 2011 Jan;151(1):18-23.e1 –
5. Cornea. 1998 Jan;17(1):38-56 –

6. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol 2004;15:299-304.
7. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-8.
8. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318-326.
9. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology 2003;110:1096-101.
10. Brewitt H, Sistani F. Dry eye disease: The scale of the problem. Surv Ophthalmol 2001;45:S199-S202.
11. Lemp MA. Epidemiology and classification of dry eye. Adv Exp Med Biol 1998;438:791-803.
12. Ashley Behrens, M.D. et al. Dysfunctional Tear Syndrome: A Delphi Approach to Treatment Recommendations, September 2006 Cornea. Bita E, Dominick G, Linda L, et al. Canalicular and nasolacrimal duct blockage: anocular side effect associated with the antineoplastic drug S-1. Am J Ophtalmol. 2005;140:325–7.13. Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2007;9:215–21.

13. Narahara H, Iishi H, Imamura H, et al. Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer. 2011;14:72–80.

14. Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009;10:1063–9.Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

15. Kanazawa T, Tanakaya K, Takeuchi H, et al. Two cases of lacrimal duct occlusion caused by S-1 therapy in patients with gastrointestinal cancer. J Jpn Coll Surg. 2008;33:150–4.
16. Prasad S, Kamath GG, Phillips RP. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy. Acta Ophthalmol Scand. 2000;78:110–3.
17. Eiseman AS, Flanagan JC, Brooks AB, et al. Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthal Plast Reconstr Surg. 2003;19:216–24.
18. Kim N, Park C, Park DJ, et al. Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy. Ann Oncol. 2012;23:2065–71.
19. Park J-S, Ha SW, Lew H. Two cases of lacrimal drainage obstruction associated with S-1 anticancer treatment. J Korean Ophthalmol Soc. 2010;51:890–4.
20. Kitamura H, Miyanaga T, Shin H, et al. Investigation of epiphora following S-1 therapy. Jpn J Cancer Chemother. 2011;38:259–62.
21. Shioda K, Tanabe K, Kimura S, et al. Treatment of severe canalicular blockage secondary to peroral TS-1. Jan J Clin Ophthalmol. 2009;63:1499–502.
22. Kashiwagi H. Ocular disorders of anticancer drugs—ocular side effects. Jpn J Cancer Chemother. 2010;37:1639–44.
23. Sakai J, Inoue Y, Kashiwagi H, et al. Multi-institutional survey on the lacrimal side effects of TS-1. Jan J Clin Ophthalmol. 2012;66:271–4.
24. Sasaki T, Miyashita H, Miyanaga T, et al. Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancerdrug. Jpn J Ophthalmol. 2012;56:214–8.
25. Ito S, Tanaka A. Three cases of corneal disorders associated with an oral anticancer drug S-1. Nippon Ganka Gakkai Zasshi. 2006;110:919–23.
26. Shibahara H, Kuze S, Kyokane T, et al. Optic lesions in patients with epiphora during S-1 therapy. Jpn J Cancer Chemother. 2010;37:1735–9.
27. Kashiwagi H. Lacrimal drainage obstruction and stenosis associated with anti-cancer drug S-1. J Eye. 2013;30:915–21.
28. Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta‐analysis,M. Calderón, M. Penagos, A. Sheikh, G. Canonica, S. Durham,Clinical and experimental allergy : journal of…2011,Corpus ID: 21109382

29. Background. Allergic conjunctivitis (AC) is a common manifestation and represents an important co‐morbidity of allergic rhinitis… Expand  2009

30. Efficlen sublingual immunotherapy tabletsacy and safety of 5-grass-pol in pediatric allergic rhinoconjunctivitis. U. Wahn, A. Tabar, +4 authors M. Le Gall,The Journal of allergy and clinical immunology,2009,Corpus ID: 1454054,BACKGROUND The efficacy and safety of the 300-index of reactivity (IR) dose of 5-grass-pollen sublingual immunotherapy (SLIT… Expand 2008

31. Mediterranean diet is associated with reduced asthma and rhinitis in Mexican children,J. de Batlle, J. Garcia-Aymerich, A. Barraza-Villarreal, J. Antó, I. Romieu,Allergy,2008 Corpus ID: 12479607,Background:  Diet during pregnancy and childhood has been suggested to play an important role in children’s asthma risk. We… Expand, 2007

32. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. A. Didier, H. Malling, +6 authors M. Mélac,The Journal of allergy and clinical immunology,2007,Corpus ID: 23133143,BACKGROUND Sublingual immunotherapy is well tolerated and data suggest its effectiveness for the treatment of allergic rhinitis… Expand,2005

33. Understanding the symptoms of the common cold and influenza,R. Eccles,The Lancet Infectious Diseases,2005,Corpus ID: 23226586,Summary The common cold and influenza (flu) are the most common syndromes of infection in human beings. These diseases are… Expand,2003

34. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. F. Simons, B. Prenner, A. Finn,The Journal of allergy and clinical immunology,2003,Corpus ID: 40847465,BACKGROUND The evidence base for the use of H1-antihistamines in the treatment of perennial allergic rhinitis is considerably… Expand,2001

35. Situation analysis of water quality in the Umtata River catchment.O. Fatoki, N. Muyima, N. Lujiza.2001,Corpus ID: 18395709,The Umtata River was characterised by using standard physico-chemical and microbiological methods to assess the present water… 1997

36. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC),D. Strachan, B. Sibbald, +22 authors H. Williams,Pediatric allergy and immunology : official…1997Corpus ID: 23608905 Background: As part of the International Study of Asthma and Allergies in Childhood (ISAAC), prevalence surveys were conducted… Expand 1997

37. Prevalence of allergic rhinitis in the United States,R. Nathan, E. Meltzer, John C. Seiner, W. Storms,1997,Corpus ID: 73123156

The study objective was to examine the current national prevalence of allergic rhinitis by gender, age, geographic region… Expand,1987

38. Epidemiological-environmental study of diesel bus garage workers: acute effects of NO2 and respirable particulate on the respiratory system.,J. Gamble, W. Jones, S. Minshall,Environmental research,1987,Corpus ID: 31014020, Personal samples of nitrogen dioxide (NO2) and respirable particulate (RP) were collected over the shift on 232 workers in four… Expand